埼玉医科大学病院は、埼玉県入間郡毛呂山町の埼玉医科大学毛呂山キャンパスにある大学病院である。

During the past decade, Saitama Medical University Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 7 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 7 clinical trials were completed. i.e. 36.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saitama Medical University Hospital" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Pfizer" with 5 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Bioverativ, a Sanofi company" with 2 trials sponsored and "Janssen Pharmaceutical K.K." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Medical University Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Saitama Medical University Hospital" are "Generalized Pustular Psoriasis" (3 trials), "Migraine" (3 trials), "Hemophilia A" (2 trials), "Agglutinin Disease, Cold" (1 trials) and "Alzheimer´s Disease" (1 trials). Many other conditions were trialed in "Saitama Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Saitama Medical University Hospital" are "Drug" (26 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "BI 685509" (2 trials), "Dexamethasone" (2 trials), "Nintedanib" (2 trials) and "Spesolimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saitama Medical University Hospital" are 26 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Saitama Medical University Hospital". undefined are not yet recruiting, 12 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Saitama Medical University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saitama Medical University Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".